Emphasizing the clinical importance of this pathophysiologic relation, C-reactive protein (CRP) and albumin have been selected from an extensive range of laboratory parameters to build a prognostic score termed modified Glasgow Prognostic Score, which has widely been validated in cancer patients since the initial description [37, 38]. The gene discussed is CRP; the disease is cancer.